Allworth Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-484
| Closed | -$1.77K | – | 4210 |
|
|
2024
Q4 | $1.77K | Sell |
484
-331
| -41% | -$1.21K | ﹤0.01% | 3192 |
|
|
2024
Q3 | $4.23K | Hold |
815
| – | – | ﹤0.01% | 2639 |
|
|
2024
Q2 | $2.96K | Sell |
815
-5
| -0.6% | -$18 | ﹤0.01% | 2750 |
|
|
2024
Q1 | $4.04K | Buy |
820
+753
| +1,124% | +$3.71K | ﹤0.01% | 2497 |
|
|
2023
Q4 | $590 | Sell |
67
-65
| -49% | -$572 | ﹤0.01% | 3097 |
|
|
2023
Q3 | $1.52K | Hold |
132
| – | – | ﹤0.01% | 2673 |
|
|
2023
Q2 | $3.34K | Sell |
132
-300
| -69% | -$7.6K | ﹤0.01% | 2278 |
|
|
2023
Q1 | $13.9K | Hold |
432
| – | – | ﹤0.01% | 1656 |
|
|
2022
Q4 | $7.98K | Hold |
432
| – | – | ﹤0.01% | 1754 |
|
|
2022
Q3 | $12K | Buy |
432
+81
| +23% | +$2.25K | ﹤0.01% | 1588 |
|
|
2022
Q2 | $5K | Sell |
351
-17
| -5% | -$242 | ﹤0.01% | 1777 |
|
|
2022
Q1 | $7K | Sell |
368
-959
| -72% | -$18.2K | ﹤0.01% | 1575 |
|
|
2021
Q4 | $22K | Buy |
1,327
+976
| +278% | +$16.2K | ﹤0.01% | 1096 |
|
|
2021
Q3 | $10K | Buy |
351
+51
| +17% | +$1.45K | ﹤0.01% | 1357 |
|
|
2021
Q2 | $9K | Hold |
300
| – | – | ﹤0.01% | 1081 |
|
|
2021
Q1 | $8K | Hold |
300
| – | – | ﹤0.01% | 1045 |
|
|
2020
Q4 | $9K | Buy |
+300
| New | +$9K | ﹤0.01% | 867 |
|